Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2024
Durvalumab Versus Chemotherapy as First-line Treatment for Metastatic NSCLC With Tumor PD-L1 Expression of 25% or Higher: Results From the Randomized Phase 3 PEARL StudyShun Lu, Lin Wu, Qiming Wang, et al.
The Journal of Nutritional Biochemistry|November 4, 2020
Pinto beans modulate the gut microbiome, augment MHC II protein, and antimicrobial peptide gene expression in mice fed a normal or western-style dietBabajide A Ojo, Peiran Lu, Sanmi E Alake, et al.
Frontiers in Oncology|October 4, 2021
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical ReviewByeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapyAsanka R Wijetunga, Terence C Chua, Christopher B Nahm, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 8, 2017
Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancersAvani D Rao, Stephanie Coquia, Robert De Jong, et al.
Translational Lung Cancer Research|May 20, 2021
Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinibPei N Ding, Tara L Roberts, Wei Chua, et al.
British Journal of Cancer|February 19, 2016
A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesotheliomaSteven C Kao, Michaela B Kirschner, Wendy A Cooper, et al.
The Lancet. Oncology|September 6, 2017
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation studyNico van Zandwijk, Nick Pavlakis, Steven C Kao, et al.
Oncotarget|October 10, 2015
MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaAnthony R Glover, Jing Ting Zhao, Anthony J Gill, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitorsJia Liu, Malinda Itchins, Adnan Nagrial, et al.
Pageof 20